Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synapsing's Multinational Sociodemographic Study

NCT07239843 is registered in ClinicalTrials.gov with Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau as lead sponsor.

NCT NCT07239843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07239843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synapsing's Multinational Sociodemographic Study
Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 1, 2026
Completion date
December 30, 2029
Enrollment
1,310 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, bipolar 1 disorder, dementia with lewy bodies (dlb), frontotemporal dementia (ftd), major depressive disorder (mdd), parkinson disease, schizophenia disorder